Skip to main content
. 2020 Jun 22;53:e20200026. doi: 10.1590/0037-8682-0026-2020

TABLE 2: Distribution of TLR3 SNP genotypes in HTLV-infected cases and healthy controls.

SNP Model Genotype Genotype frequencies; n (%) p a OR (95% CI)
HTLV-infected (100 cases) Healthy (118 controls)
rs3775296 Codominant CC 70 (70.0%) 60 (50.8%) _ ref
CA 24 (24.0%) 53 (44.9%) 0.002 0.388 (0.215-0.702)
AA 6 (6.0%) 5 (4.2%) 0.964 1.029 (0.299-3.540)
Dominant CC 70 (70.0%) 60 (50.8%) _ ref
CA + AA 30 (30.0%) 58 (49.2%) 0.004 0.443 (0.253-0.776)
Recessive CC + CA 94 (94%) 113 (95.8%) _ ref
AA 6 (6.0%) 5 (4.2%) 0.554 1.443 (0.427-4.876)
rs3775291 Codominant CC 52 (52.0%) 55 (46.6%) _ ref
CT 43 (43.0%) 56 (47.5%) 0.458 0.812 (0.469-1.407)
TT 5 (5.0%) 7 (5.9%) 0.649 0.755 (0.226-2.530)
Dominant CC 52 (52.0%) 55 (46.6%) _ ref
CT + TT 48 (48.0%) 63 (53.4%) 0.428 0.806 (0.473-1.374)
Recessive CC + CT 95 (95%) 111 (94.1%) _ ref
TT 5 (5.0%) 7 (5.9%) 0.764 0.835 (0.256-2.716)

a: P values were calculated using χ 2 test; SNP: single nuclear polymorphism, OR: odds ratio, CI: confidence interval.